混合心脏性休克:关于标准化分类,血液动力学定义和管理框架的建议
Sean van Diepen1, Janine Pöss2, Janek M Senaratne1
1Department of Critical Care Medicine and Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Canada (S.v.D., J.M.S.).
Circulation
|October 28, 2024
概括
心脏性休克 (CS) 分类现在可以识别除了冷湿的状态之外的混合状态. 这项研究提出了一个新的框架,以更好地分类和管理这些复杂的CS介绍.
科学领域:
- 心脏病学
- 重症监护医疗
- 血液动力学
背景情况:
- 心脏性休克 (CS) 的分类已经超出了单一的血液动力学特征.
- 目前的数据显示了CS敏度,原因,体积状况和血管抵抗的显著变化.
- 混合CS,定义为至少有一个额外的冲击状态的CS,是重症监护室中冲击的第二大原因.
研究的目的:
- 总结一下目前心脏病的流行病学情况.
- 提出一个新的混合CS分类框架.
- 建议用于分类和管理混合CS的侵入性血液动力学参数.
主要方法:
- 对心脏性休克的当前文献和注册数据的审查.
- 在CS状态混合的患者中分析血液动力学概况.
- 拟议的分类系统和诊断参数的开发.
主要成果:
- 混合CS状态在呈现和潜在因素方面表现出相当多的异质性.
- 现有的分类系统和证据不足以指导混合CS护理.
- 一个拟议的框架旨在标准化表型和管理策略.
结论:
- 一个精细的CS理解承认不同的呈现,包括混合的冲击状态.
- 标准化分类和血液动力学定义对于推进混合CS研究和临床实践至关重要.
- 拟议的框架提供了更好的患者表型和针对性管理的途径.
相关概念视频
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.7K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.7K
Heart Failure IV: Classification and Diagnostic Evaluation
1.2K
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
1.2K
Heart Failure V: Medical Management
641
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
641
Cardiomyopathy I: Introduction and Classification
828
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
828
Cardiomyopathy II: Dilated Cardiomyopathy
798
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798
Cardiomyopathy III: Hypertrophic Cardiomyopathy
810
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810


